CTLA-4 regulates cell cycle progression during a primary immune response
Rebecca J. Greenwald(Brigham and Women's Hospital), Arlene H. Sharpe(Brigham and Women's Hospital), Didier A. Mandelbrot(UW Health University Hospital), Vassiliki A. Boussiotis(Beth Israel Deaconess Medical Center), Anup Kubal(Brigham and Women's Hospital), Diane van der Woude(Leiden University Medical Center), Mariëtte A. Oosterwegel(University Medical Center Utrecht)
European Journal of Immunology
February 1, 2002
Cited by 122
Related Papers
PD-1 and Its Ligands in Tolerance and Immunity
|Annual Review of Immunology|2008|5.3k
PD-L2 is a second ligand for PD-1 and inhibits T cell activation
|Nature Immunology|2001|3k
PD-L1 regulates the development, maintenance, and function of induced regulatory T cells
|The Journal of Experimental Medicine|2009|2k
Molecular and Biochemical Aspects of the PD-1 Checkpoint Pathway
|New England Journal of Medicine|2016|1.4k
Increased Energy Expenditure, Decreased Adiposity, and Tissue-Specific Insulin Sensitivity in Protein-Tyrosine Phosphatase 1B-Deficient Mice
|Molecular and Cellular Biology|2000|1.2k